Encapsulated islet transplantation treatment for diabetes mellitus;Behandling av diabetes mellitus transplantasjon av immunbeskyttet øyvev fra pancreas

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 28, 1999, Pages 4219-4223

  Kulseng, Bård ^a   Espevik, Terje ^a   Skjåk Bræk, Gudmund ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID;

ALLOTRANSPLANTATION; ANIMAL; DIABETES MELLITUS; DIFFUSION CHAMBER; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; MICROCAPSULE; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; REVIEW; SWINE; TRANSGENIC ANIMAL; XENOGRAFT;

ALGINATES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAPSULES; DIABETES MELLITUS; DIFFUSION CHAMBERS, CULTURE; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; SWINE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 7444270674     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Dorman JS, Laporte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 1984; 33: 271-6.
2. The Diabetes Control and Complication Trial Researsh Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-86.
3. Giroir BP, Brown T, Beutler B. Constitutive synthesis of tumor necrosis factor in the thymus. Proc Natl Acad Sci 1992; 89: 4864-8.
4. Otonkoski T, Beattie GM, Rubin JS, Lopez AD, Baird A, Hayek A. Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes 1994; 43: 947-53.
5. Sutherland DE, Moudry KC, Goetz FC, Najarian JS. Long-term outcome of pancreas transplants functioning at one year. Transplant Proc 1989; 21: 2845-9.
6. Coosemans W, Peeters J, Aerts R, Christiaens MR, Donck J, Vanwalleghem J et al. Complications and outcome of combined kidney-pancreas transplantation for end-stage diabetic nephropathy: a retrospective single-center analysis. Leuven Collaborative Group for Transplantation. Transplant Proc 1998: 30: 274-5.
7. Troppmann C, Gruessner AC, Dunn DL, Sutherland DE, Gruessner RW. Surgical complications requiring early relaparotomy after pancreas transplantation: a multivariate risk factor and economic impact analysis of the cyclosporine era. Ann Surg 1998; 227: 255-68.
8. Brekke IB. Vascularised pancreas transplantation. Ann Chir Gynaecol 1997; 86: 152-4.
9. Pirsch JD, Andrews C, Hricik DE, Josephson MA, Leichtman AB, Lu CY et al. Pancreas transplantation for diabetes mellitus. Am J Kidney Dis 1996; 27: 444-50.
10. Secchi A, Martinenghi S, Castoldi R, Giudici D, Di Carlo V, Pozza G. Effects of pancreas transplantation on quality of life in type I diabetic patients undergoing kidney transplantation. Transplant Proc 1998; 30: 339-42.
11. Goldstein DJ, Austin JH, Zuech N, Williams DL, Stoopler MB, Michler RE et al. Carcinoma of the lung after heart transplantation. Transplantation 1996; 62: 772-5.
12. Yoshimura N, Oka T. Medical and surgical complications of renal transplantation: diagnosis and management. Med Clin North Am 1990; 74: 1025-37.
13. Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994; 344: 1402-4.
14. Korsgren O, Sandler S, Landstrom AS, Jansson L, Andersson A. Large-scale production of fetal porcine pancreatic isletlike cell clusters. An experimental tool for studies of islet cell differentiation and xenotransplantation. Transplantation 1988; 45: 509-14.
15. Korsgren O, Andersson A, Sandler S. Pretreatment of fetal porcine pancreas in culture with nicotinamide accelerates reversal of diabetes after transplantation to nude mice. Surgery 1993; 113: 205-14.
16. Heneine W, Tibell A, Switzer WM, Sandstrom P, Rosales GV, Mathews A et al. No evidence of infection with-porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998; 29: 695-9.
17. Lanza RP, Chick WL. Immunoisolation: at a turning point. Immunol Today 1997; 18: 135-9.
18. Click WL, Like AA, Lauris V. Beta cell culture on synthetic capillaries: an artificial endocrine pancreas. Science 1975; 187: 847-9.
19. Sullivan SJ, Maki T, Borland KM, Mahoney MD, Solomon BA, Muller TE et al. Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. Science 1991; 252: 718-21.
20. Lanza RP, Butler DH, Borland KM, Staruk JE, Faustman DL, Solomon BA et al. Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression. Proc Natl Acad Sci 1991; 88: 11100-4.
21. Colton CK. Implantable biohybrid artificial organs. Cell Transplant 1995; 4: 415-36.
22. Colton CK, Avgoustiniatos ES. Bioengineering in development of the hybrid artificial pancreas. J Biomech Eng 1991; 113: 152-70.
23. Soon Shiong P. Feldman E, Nelson R, Smidsrod O, Skjak Braek G, Espevik T et al. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 1992; 54: 769-74.
24. Soon Shiong P, Feldman E, Nelson R, Heintz R, Merideth N, Skjak Braek G et al. Long-term reversal of diabetes by the injection of immaunoprotectcd islets. Proc Natl Acad Sci 1993: 90: 5843-7.
25. De Vos P, De Haan BJ, Wolters GH, Strubbe JH, Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 1997; 40: 262-70.
26. De Berardinis P, Londei M, Kahan M, Balsano F, Kontiainen S, Bottazzo GF et al The majority of the activated T cells in the blood of insulindependent diabetes mellitus (IDDM) patients are CD4+. Clin Exp Immunol 1988; 73: 255-9.
27. Sun YL, Ma X, Zhou D, Vacek I, Sun AM. Porcine pancreatic islets: isolation, microencapsulation, and xenotransplantation. Artif Organs 1993; 17: 727-33.
28. Lanza RP, Kuhtreiber WM, Ecker D, Staruk JE, Chick WL. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 1995; 59: 1377-84.
29. Thu B, Bruheim P, Espevik T, Smidsrod O, Soon Shiong P, Skjak Braek G. Alginate polycation microcapsules. L Interaction between alginate and polycation. Biomaterials 1996; 17: 1031-40.
30. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996; 98: 1417-22.
31. Soon Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994; 343: 950-1.
32. Soon Shiong P, Sandford P. Encapsulated islet cell therapy for the treatment of diabetes: intraperitoneal injection of islets. Surgical Technology International IV 1995; 93-9.
33. Ertesvag H, Hoidal HK, Hals IK, Rian A, Doseth B, Valla S. A family of modular type mannuronan C-5-epimerase genes controls alginate structure in Azotobacter vinelandii. Mol Microbiol 1995; 16: 719-31.
34. Ertesvag H, Doseth B, Larsen B, Skjak Braek G, Valla S. Cloning and expression of an Azotobacter vinelandii mannuronan C-5-epimerase gene. J Bacteriol 1994; 176: 2846-53.
35. Kulseng B,Thu B, Espevik T, Skjåk-Bræk G. Alginate poylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulines over the capsule membrane. Cell Transplantation 1997; 6: 387-94.
36. Otterlei M, Ostgaard K, Skjak Braek G, Smidsrod O, Soon Shiong P, Espevik T. Induction of cytokine production from human monocytes stimulated with alginate. J Immunother 1991; 10: 286-91.
37. Kulseng B, Skjak Braek G, Folling I, Espevik T. TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide. Scand J Immunol 1996; 43: 335-40.
38. Skjåk-Bræk G, Grasdalen H, Smidsrød O. Inhomogeneous polysaccharide ionic gel. Carbohydr Polym 1989; 10: 31-54.
39. Thu B, Bruheim P, Espevik T, Smidsrod O, Soon Shiong P, Skjak Braek G. Alginate polycation microcapsules. II. Some functional properties. Biomaterials 1996; 17: 1069-79.
40. Schrezenmeir J, Gero L, Laue C, Kirchgessner J, Muller A, Huls A et al. The role of oxygen supply in islet transplantation. Transplant Proc 1992; 24: 2925-9.
41. Keymeulen B, Ling Z, Gorus FK, Delvaux G, Bouwens L, Grupping A et al. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 1998; 41: 452-9.
42. Kulseng B, Skjak-Braek G, Ryan L, Andersson A, King A, Faxvåg A et al. Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine isletlike cell clusters. Transplantation 1999; 67: 978-84.
43. Eizirik DL, Sandier S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller DA et al Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 1994; 93: 1968-74.
44. Lanza RP, Beyer AM, Chick WL. Xenogenic humoral responses to islets transplanted in biohybrid diffusion chambers. Transplantation 1994; 57: 1371-5.